Attachment A - Salient Characteristics - MSI Testing CPK.docx
DOCX document 16 KB Posted
- Attached to
- 6550--Molecular Oncology-MSI Testing Federal contract opportunity
- Solicitation number
- 36C26226Q0730
About this file
This is a Salient Characteristics attachment defining the technical and operational requirements for MSI Testing Reagent Cartridges under a Request for Quotation issued by the Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 22 (VA Greater Los Angeles). The solicitation number is 36C26226Q0730, and this is a commercial products acquisition not set-aside for small business concerns.
The specified assay must be fully automated and ready-to-use with no reagent preparation required. Key performance characteristics include delivery of results within approximately 150 minutes, no sample extraction needed prior to testing, capability to perform testing on a minimum of one FFPE tissue section, elimination of external quality control requirements, and qualitative detection of mutations across seven novel MSI loci (ACVR2A, BTBD7, DIDO1, MRE11, RYR3, SEC31A, and SULF2). Pricing must be structured on a reagent rental basis that includes coverage of the reagent cartridge kits themselves, the Idylla Instrument and Console, and annual preventative maintenance service. The solicitation is issued under the simplified acquisition procedures for commercial items in accordance with FAR Part 12.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| 36C26226Q0730_1.docx | DOCX document | |
| 36C26226Q0730.docx | DOCX document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
SALIENT CHARACTERISTICS
MSI Testing Reagent Cartridges
1. The assay shall be fully automated, ready to made reagent with no reagent preparation required.
2. The assay shall provide the following MSI testing characteristics:
a. Provide a result in approximately 150 minutes.
b. No sample extraction required prior to use.
c. Testing volume that can be performed on a minimum of 1 slice of FFPE tissue section.
d. Eliminate use of external quality control.
e. Qualitative detection of mutations in 7 novel MSI loci (ACVR2A, BTBD7, DIDO1, MRE11, RYR3, SEC31A, and SULF2).
3. Price of reagent cartridge kits must be on reagent rental basis to include coverage of:
a. Reagent cartridge kits
b. Idylla Instrument and Console
c. Annual preventative maintenance (PM) service
File details come from the government source that posted it. Updated .